Skip to main content
Clinical Trials/NCT02070562
NCT02070562
Unknown
Not Applicable

Human Milk Profiles and Dietary Intake of Chinese Lactating Mothers During Early Lactation Period in Shanghai

Dumex Baby Food Co., Ltd.1 site in 1 country120 target enrollmentFebruary 2014
ConditionsBreast Milk

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Breast Milk
Sponsor
Dumex Baby Food Co., Ltd.
Enrollment
120
Locations
1
Primary Endpoint
Breast milk composition
Last Updated
11 years ago

Overview

Brief Summary

This study aims to investigate breast milk composition and dietary habits of Chinese lactating mothers. Further understanding of the composition of human milk will help to understand the nutritional needs of mothers and their infants in their early phase of life which eventually will help to support breastfeeding.

Registry
clinicaltrials.gov
Start Date
February 2014
End Date
June 2016
Last Updated
11 years ago
Study Type
Observational
Sex
Female

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Generally healthy mothers who give birth to a healthy term infant (37-42 weeks) whose birth weight is \>10 and \<90 percentiles gestational birth weight chart.
  • Aged 20 - 40 years.
  • Mothers who intend to exclusively breastfeed the infant for more than 6 weeks.
  • Chinese ethnicity, including both parents.
  • Mothers who sign the informed consent form in writing.

Exclusion Criteria

  • Participation in any other studies involving investigational or marketed products concomitantly or two weeks prior to entry into the study.
  • Difficult to follow up and/or locate (e.g. known transfer to other hospitals, residing outside Shanghai, plan to move out of Shanghai).
  • Current smoker or having smoked during the pregnancy.
  • Having consumed alcoholic drinks during pregnancy or lactation.
  • Illegal drug abuser: cannabinoids (marijuana, hashish), stimulants (cocaine, amphetamine, methamphetamine), opioid (heroin, opium).
  • Acute infection disease or neoplastic disease or any kind of weakening or debilitating conditions (no history of positive HBV, HCV or HIV serological test at any time during the pregnancy).
  • Use of drug or pharmacologically active substances (e.g. herbal products, traditional medicine) to treat a particular disease or medical condition from the beginning of lactation ( those who consume herbal/traditional medicine for maintaining or improving well-being will still be included).
  • Presence of mastitis, fungal infections of the nipple or areola; reactivation of herpes simplex (HSV) or varicella zoster infection in the mammary or thoracic region at the time of enrolment.
  • Presence of endocrinology diseases, particularly diabetes mellitus and gestational diabetes.
  • Presence of obesity (pre-pregnancy BMI \> 28).

Outcomes

Primary Outcomes

Breast milk composition

Time Frame: 0-42 day postpartum

Human milk oligosaccharides profiles, fatty acids profile, macronutrients and energy content will be measured.

Secondary Outcomes

  • Growth(0-42 day postpartum)
  • Maternal diet survey(0-42 day postpartum)
  • Infection(0-42 day postpartum)

Study Sites (1)

Loading locations...

Similar Trials